OncoCyte - 9 Year Stock Price History | OCX
Historical daily share price chart and data for OncoCyte since 2016 adjusted for splits and dividends. The latest closing stock price for OncoCyte as of February 21, 2025 is 2.65.
- The all-time high OncoCyte stock closing price was 202.20 on January 05, 2016.
- The OncoCyte 52-week high stock price is 3.48, which is 31.3% above the current share price.
- The OncoCyte 52-week low stock price is 1.92, which is 27.5% below the current share price.
- The average OncoCyte stock price for the last 52 weeks is 2.78.
| OncoCyte Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 2.2276 | 2.3300 | 2.7600 | 1.9600 | 2.6500 | 11.34% |
| 2024 | 2.9132 | 3.3000 | 3.6000 | 2.1100 | 2.3800 | -4.80% |
| 2023 | 4.8032 | 6.9000 | 9.7600 | 2.0800 | 2.5000 | -61.05% |
| 2022 | 20.6961 | 45.0000 | 45.0000 | 5.0800 | 6.4180 | -85.21% |
| 2021 | 85.2167 | 47.8000 | 130.0000 | 40.8000 | 43.4000 | -9.21% |
| 2020 | 41.4055 | 44.6000 | 69.0000 | 24.0000 | 47.8000 | 6.22% |
| 2019 | 55.5357 | 29.4000 | 118.2000 | 29.4000 | 45.0000 | 63.04% |
| 2018 | 50.6016 | 92.0000 | 92.0000 | 25.0000 | 27.6000 | -70.32% |
| 2017 | 111.6787 | 135.0000 | 151.0000 | 72.0000 | 93.0000 | -34.04% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.047B | $0.002B |
| OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.197B | 27.76 |
| Elevance Health (ELV) | United States | $90.566B | 11.84 |
| CVS Health (CVS) | United States | $82.065B | 12.01 |
| Cencora (COR) | United States | $47.211B | 17.13 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Natera (NTRA) | United States | $22.205B | 0.00 |
| ICON (ICLR) | Ireland | $16.651B | 14.81 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Doximity (DOCS) | United States | $14.002B | 72.82 |
| Revvity (RVTY) | United States | $13.962B | 23.41 |
| Viatris (VTRS) | United States | $13.201B | 4.07 |
| Solventum (SOLV) | United States | $12.870B | 0.00 |
| Avantor (AVTR) | United States | $11.909B | 17.49 |
| CochLear (CHEOY) | Australia | $11.330B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.506B | 27.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.794B | 0.00 |
| HealthEquity (HQY) | United States | $9.682B | 48.57 |
| Sonic Healthcare (SKHHY) | Australia | $8.686B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.297B | 15.72 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.601B | 25.63 |
| Organon (OGN) | United States | $4.041B | 4.12 |
| Sotera Health (SHC) | United States | $3.829B | 20.49 |
| BrightSpring Health Services (BTSG) | United States | $3.552B | 75.56 |
| Surgery Partners (SGRY) | United States | $3.263B | 37.20 |
| Concentras Parent (CON) | United States | $2.981B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.791B | 338.60 |
| Alignment Healthcare (ALHC) | United States | $2.755B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.185B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.118B | 0.00 |
| Progyny (PGNY) | United States | $2.033B | 41.17 |
| PACS (PACS) | United States | $2.010B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.852B | 48.60 |
| Premier (PINC) | United States | $1.726B | 11.05 |
| Agilon Health (AGL) | United States | $1.492B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.480B | 12.40 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.254B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 7.81 |
| Establishment Labs Holdings (ESTA) | $0.981B | 0.00 | |
| Embecta (EMBC) | United States | $0.838B | 5.74 |
| Auna S.A (AUNA) | Luxembourg | $0.611B | 0.00 |
| DocGo (DCGO) | United States | $0.513B | 19.35 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
| MultiPlan (MPLN) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.424B | 36.70 |
| Nutex Health (NUTX) | United States | $0.335B | 0.00 |
| LifeMD (LFMD) | United States | $0.326B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.311B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.199B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.134B | 0.00 |
| So-Young (SY) | China | $0.114B | 19.40 |
| IceCure Medical (ICCM) | Israel | $0.083B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| ModivCare (MODV) | United States | $0.079B | 4.29 |
| Oncology Institute (TOI) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.62 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
| KindlyMD (KDLY) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |